Ultrasound-augmented enzyodynamic-Ca2+ overload synergetic tumor nanotherapy
- PMID: 38432005
- DOI: 10.1016/j.biomaterials.2024.122513
Ultrasound-augmented enzyodynamic-Ca2+ overload synergetic tumor nanotherapy
Abstract
The excessive intracellular Ca2+ can induce oxidative stress, mitochondrial damage and cell apoptosis, which has been extensively explored for tumor therapy. However, the low Ca2+ accumulation originated from Ca2+-based nanosystems substantially weakens the therapeutic effect. Herein, a functional plant polyphenol-appended enzyodynamic nanozyme system CaFe2O4@BSA-curcumin (abbreviation as CFO-CUR) has been rationally designed and engineered to achieve magnified Ca2+ accumulation process, deleterious reactive oxygen species (ROS) production, as well as mitochondrial dysfunction through enzyodynamic-Ca2+ overload synergistic effect. The exogenous Ca2+ released by CaFe2O4 nanozymes under the weakly acidic tumor microenvironment and Ca2+ efflux inhibition by curcumin boost mitochondria-dominant antineoplastic efficiency. The presence of Fe components with multivalent characteristic depletes endogenous glutathione and outputs the incremental ROS due to the oxidase-, peroxidase-, glutathione peroxidase-mimicking activities. The ROS burst-triggered regulation of Ca2+ channels and pumps strengthens the intracellular Ca2+ accumulation. Especially, the exogenous ultrasound stimulation further amplifies mitochondrial damage. Both in vitro and in vivo experimental results affirm the ultrasound-augmented enzyodynamic-Ca2+ overload synergetic tumor inhibition outcomes. This study highlights the role of ultrasound coupled with functional nanozyme in the homeostasis imbalance and function disorder of mitochondria for highly efficient tumor treatment.
Keywords: Ca(2+) overload; Curcumin; Mitochondrial dysfunction; Multienzyme-mimicking; Ultrasound.
Copyright © 2024. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
2D Catalytic Nanozyme Enables Cascade Enzyodynamic Effect-Boosted and Ca2+ Overload-Induced Synergistic Ferroptosis/Apoptosis in Tumor.Adv Mater. 2024 Jun;36(24):e2312316. doi: 10.1002/adma.202312316. Epub 2024 Mar 28. Adv Mater. 2024. PMID: 38501540
-
Ultrasound-Amplified Enzyodynamic Tumor Therapy by Perovskite Nanoenzyme-Enabled Cell Pyroptosis and Cascade Catalysis.Adv Mater. 2023 Feb;35(7):e2208817. doi: 10.1002/adma.202208817. Epub 2022 Dec 18. Adv Mater. 2023. PMID: 36529686
-
A Calcium Fluoride Nanozyme for Ultrasound-Amplified and Ca2+ -Overload-Enhanced Catalytic Tumor Nanotherapy.Adv Mater. 2022 Oct;34(43):e2205680. doi: 10.1002/adma.202205680. Epub 2022 Sep 26. Adv Mater. 2022. PMID: 36106691
-
Pathological and Pharmacological Roles of Mitochondrial Reactive Oxygen Species in Malignant Neoplasms: Therapies Involving Chemical Compounds, Natural Products, and Photosensitizers.Molecules. 2020 Nov 11;25(22):5252. doi: 10.3390/molecules25225252. Molecules. 2020. PMID: 33187225 Free PMC article. Review.
-
Mitochondria as a target in the therapeutic properties of curcumin.Arch Pharm (Weinheim). 2014 Dec;347(12):873-84. doi: 10.1002/ardp.201400266. Epub 2014 Sep 22. Arch Pharm (Weinheim). 2014. PMID: 25243820 Review.
Cited by
-
Towards precision medicine: design considerations for nanozymes in tumor treatment.J Transl Med. 2024 Nov 16;22(1):1033. doi: 10.1186/s12967-024-05845-w. J Transl Med. 2024. PMID: 39550581 Free PMC article. Review.
-
Self-Sustained Biophotocatalytic Nano-Organelle Reactors with Programmable DNA Switches for Combating Tumor Metastasis.Adv Mater. 2025 Mar;37(9):e2415030. doi: 10.1002/adma.202415030. Epub 2025 Jan 10. Adv Mater. 2025. PMID: 39797479 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous